Catalyst Wire Dossier Catalyst Wire Dossier

0.75% Phentolamine Ophthalmic Solution

phentolamine · Ocuphire Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 0.75% Phentolamine Ophthalmic Solution, covering 2026-03-12 to 2026-08-18. Get the full timeline:

Most recent: Clinical Trial Results: Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances [Phase 3]

See pricing